Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$245K Buy
888
+25
+3% +$7.06K 0.04% 174
2026
Q1
$230K Buy
863
+81
+10% +$22.4K 0.04% 165
2025
Q4
$215K Sell
782
-66
-8% -$18.5K 0.04% 158
2025
Q3
$244K Sell
848
-36
-4% -$10.7K 0.05% 150
2025
Q2
$292K Buy
884
+43
+5% +$13.9K 0.07% 135
2025
Q1
$277K Buy
841
+79
+10% +$23.8K 0.07% 131
2024
Q4
$210K Sell
762
-1
-0.1% -$319 0.06% 153
2024
Q3
$264K Buy
763
+9
+1% +$3.1K 0.08% 135
2024
Q2
$249K Sell
754
-52
-6% -$17.9K 0.08% 134
2024
Q1
$293K Buy
806
+65
+9% +$21.4K 0.1% 118
2023
Q4
$222K Sell
741
-29
-4% -$8.47K 0.09% 129
2023
Q3
$220K Buy
+770
New +$220K 0.1% 125

Other funds holding CI

Verum Partners's CI Position: Q2 2026 in Review

Verum Partners increased its Cigna (CI) stake by 2.9% in Q2 2026, buying an estimated $7.06K and bringing the position to 888 shares worth $245K. The position accounts for 0.04% of the portfolio, ranked #174.

Verum Partners first reported a position in CI in Q3 2023 and has held it in 12 quarters since. The position peaked at $293K in Q1 2024. 476 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • Verum Partners held 888 shares of Cigna worth $245K as of Q2 2026.
  • Verum Partners bought 25 Cigna shares in Q2 2026, an estimated $7.06K.
  • Cigna made up 0.04% of Verum Partners's portfolio in Q2 2026, its #174 holding.
  • Verum Partners first reported a position in Cigna in Q3 2023 and has held it in 12 quarters since.
  • Verum Partners's Cigna position peaked at $293K in Q1 2024.
  • 476 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Verum Partners's 13F filing for Q2 2026, filed 22 Jul 2026.